EZZ Life Science Holdings Limited is a genomic life science and biotechnology company focused on developing products that aim to improve quality of life and human health. Established in 2015 and headquartered in Australia, the company’s primary activities encompass the formulation, production, marketing, and sale of branded health and wellness products, with distribution reaching Australia, New Zealand, Mainland China, and other international markets. EZZ Life Science is particularly distinguished by its commitment to genomic research, concentrating efforts on four key health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. Alongside its own EZZ-branded portfolio, the company is also engaged in the wholesale distribution of EAORON skincare products in Australia and New Zealand. EZZ Life Science Holdings Limited plays a significant role in the intersection of healthcare, biotechnology, and consumer health sectors, blending scientific innovation with accessible wellness solutions. Its omnichannel approach spans both retail and direct-to-consumer e-commerce, supporting broad market reach. The company’s research-driven model aims to respond to global trends in personalized and preventative healthcare, making it a pivotal player in the rapidly evolving life sciences and wellness industry.